Clinical trial
Co-administration Study in Patients With Elevated Cholesterol and Coronary Heart…
NCT00092625 · Organon and Co, Industry · Completed
Key facts
| NCT number | NCT00092625 |
|---|---|
| Title | Co-administration Study in Patients With Elevated Cholesterol and Coronary Heart Disease (0653-803) |
| Official title | A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate Efficacy, Safety, and Tolerability of Ezetimibe 10 mg or Placebo Added to Existing Atorvastatin 10 mg or 20 mg in Attaining Low-Density Lipoprotein Cholesterol Target Levels in Patients With Hypercholesterolemia and… |
| Lead sponsor | Organon and Co, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Hypercholesterolemia, Coronary Disease |
| Intervention type | Drug |
| Interventions | MK0653, ezetimibe, Comparator: ezetimibe, placebo |
| Enrollment | 442 |
| Start date | Mar 1, 2003 |
| Primary completion | Jul 1, 2004 |
| Completion | Aug 1, 2004 |
| First posted | Sep 27, 2004 |
| Last update posted | Aug 15, 2024 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: